Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Quality Index
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Quality Index of 2.55x as of March 2025. Operating cash flow of CN¥39.75 Million exceeds net income of CN¥15.58 Million, indicating high earnings quality where cash backs reported profits. Also explore 688488 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2020)
Historical Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688488 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year earnings quality comparison for Jiangsu Aidea Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 688488 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.41x | CN¥56.17 Million | CN¥39.77 Million | ▼ -15.4% |
| 2019 | 1.67x | CN¥56.20 Million | CN¥33.65 Million | ▲ +143.0% |
| 2018 | -3.89x | CN¥-33.50 Million | CN¥8.62 Million | ▼ -276.9% |
| 2016 | 2.20x | CN¥31.29 Million | CN¥14.24 Million | — |